NAV
₹593.9416
as of 31 Jul 2026
Expense Ratio
—
see scheme documents
Lumpsum returns (CAGR)
- 1Y
- +17.46%
- 3Y
- +24.41%
- 5Y
- +18.21%
- Since Inception
- +18.37%
SIP returns (XIRR)
- 1Y
- +34.03%
- 3Y
- +22.58%
- 5Y
- +23.37%
- Since Inception
- +18.15%
Performance Comparison
Sectoral allocation
as of 30 Jun 2026- Pharmaceuticals & Biotechnology63.92%
- Healthcare Services26.05%
- Chemicals & Petrochemicals5.03%
- Healthcare Equipment & Supplies2.16%
Each sector links to the mutual funds most exposed to it.
Thinking about SBI Healthcare Opportunities Fund · Direct · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
portfolio shared with SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH
- 1Sun Pharmaceutical Industries Ltd.11.18%
- 2Acutaas Chemicals Ltd.6.35%
- 3Divi'S Laboratories Ltd.5.92%
- 4Apollo Hospitals Enterprise Ltd.5.21%
- 5Max Healthcare Institute Ltd.5.08%
- 6Aurobindo Pharma Ltd.4.17%
- 7Aster Dm Healthcare Ltd.3.77%
- 8Laurus Labs Ltd.3.64%
- 9Cipla Ltd.3.52%
- 10Torrent Pharmaceuticals Ltd.3.33%
Investment Objective
SBI Healthcare Opportunities Fund · Direct · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
SBI Healthcare Opportunities Fund · Direct · Growth is a Sectoral / Thematic mutual fund offered by SBI Mutual Fund. The fund has been operational for over 13 years.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations